Doering P L, McCormick W C, Klapp D L, Russell W L
Am J Hosp Pharm. 1981 Dec;38(12):1949-51.
Physicians consent and statutory regulations relating to therapeutic substitution are discussed. Some hospitals have adopted policies allowing the interchange of a chemically inequivalent product deemed therapeutically identical by the P & T committee. In the absence of statutory regulation, hospital pharmacists usually refer to (1) the physician's agreement to abide by hospital bylaws (including the formulary system) when joining the hospital staff, or (2) prescription blanks and order sheets preprinted with the statement "substitution permitted unless otherwise indicated" as the legal authority for therapeutic substitution. Only two states have addressed the legality of therapeutic substitution. An opinion of the Oregon Attorney General and a Washington state statute both authorize therapeutic substitution under certain circumstances if the prescriber has given prior consent. Neither of the states specifies, however, whether the agreement of prescribers to abide by hospital bylaws constitutes authorization of therapeutic substitution. It is proposed that state boards of pharmacy and state legislatures draft laws that address therapeutic substitution and specify acceptable methods of consent.
讨论了与治疗性替代相关的医生同意书和法定法规。一些医院已采用相关政策,允许更换由药品与治疗学委员会认定为治疗等效但化学上不等效的产品。在缺乏法定法规的情况下,医院药剂师通常依据以下两点进行操作:(1)医生在加入医院工作人员队伍时同意遵守医院规章制度(包括处方集系统);(2)预先印好“除非另有说明,允许替代”声明的处方笺和医嘱单,将其作为治疗性替代的法律依据。只有两个州探讨了治疗性替代的合法性。俄勒冈州总检察长的一份意见书和华盛顿州的一项法规都授权在某些情况下,如果开处方者事先同意,可进行治疗性替代。然而,这两个州均未明确规定开处方者同意遵守医院规章制度是否构成对治疗性替代的授权。建议州药房委员会和州立法机构起草涉及治疗性替代并明确可接受的同意方式的法律。